InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Kasra Kasraian
21 May 2026
Chief Technical Officer
Sell
1,233
$1.41
$1.74K
James G McArthur
4 Mar 2026
President and CEO
Sell
131
$6.33
$828.58
James G McArthur
4 Mar 2026
President and CEO
Sell
5,144
$6.23
$32.05K
Noel Donnelly
4 Mar 2026
Chief Financial Officer
Sell
52
$6.33
$328.90
Noel Donnelly
4 Mar 2026
Chief Financial Officer
Sell
2,032
$6.23
$12.66K
Paul Streck
4 Mar 2026
EVP, Head of R&D
Sell
47
$6.29
$295.54
Paul Streck
4 Mar 2026
EVP, Head of R&D
Sell
1,832
$6.23
$11.41K
Oxford Science Enterprises plc
30 Sep 2025
Former 10% Owner
Buy
200,000
$3.20
$640.00K
Ra Capital Management, L.p.
26 Sep 2025
Director
Buy indirect
9,375,000
$3.20
$30.00M
Paul Streck
30 May 2025
EVP, Head of R&D
Buy
8,375
$1.24
$10.39K
James G McArthur
17 Apr 2025
President and CEO
Buy
10,000
$1.36
$13.55K
James G McArthur
8 Apr 2025
President and CEO
Buy
41,500
$1.15
$47.73K
Noel Donnelly
26 Feb 2025
Chief Financial Officer
Sell
1,527
$1.68
$2.57K
Mary Beth DeLena
26 Feb 2025
General Counsel
Sell
1,432
$1.68
$2.41K
Michelle L Mellion
25 Jul 2024
Chief Medical Officer
Sold after exercise
7,571
$18.06
$136.74K
Michelle L Mellion
24 Jul 2024
Chief Medical Officer
Sold after exercise
201
$18.01
$3.62K
Michelle L Mellion
18 Jul 2024
Chief Medical Officer
Sold after exercise
12,625
$18.20
$229.80K
Michelle L Mellion
16 Jul 2024
Chief Medical Officer
Sold after exercise
5,901
$18.00
$106.25K
Michelle L Mellion
12 Jul 2024
Chief Medical Officer
Sold after exercise
3,288
$18.04
$59.33K
Michelle L Mellion
2 Jul 2024
Chief Medical Officer
Sold after exercise
37
$18.07
$668.59
Michelle L Mellion
1 Jul 2024
Chief Medical Officer
Sold after exercise
875
$18.01
$15.76K
Michelle L Mellion
24 Jun 2024
Chief Medical Officer
Sold after exercise
9,260
$18.19
$168.43K
Michelle L Mellion
12 Jun 2024
Chief Medical Officer
Sold after exercise
1,086
$18.06
$19.61K
Michelle L Mellion
11 Jun 2024
Chief Medical Officer
Sold after exercise
500
$18.04
$9.02K
Michelle L Mellion
6 Jun 2024
SVP, Clinical Development
Sold after exercise
1,411
$18.00
$25.40K
Michelle L Mellion
5 Jun 2024
SVP, Clinical Development
Sold after exercise
7,245
$18.09
$131.06K
Niels Svenstrup
17 May 2024
SVP, Chem. Mfg & Controls
Sell
10,000
$13.41
$134.10K
Ra Capital Management, L.p.
9 Feb 2024
Director
Buy indirect
2,557,593
$10.64
$27.21M
James G McArthur
30 Nov 2023
President and CEO
Buy
1,694
$4.17
$7.06K
James G McArthur
8 Jun 2023
President and CEO
Sold after exercise
2,381
$16.04
$38.19K
James G McArthur
7 Jun 2023
President and CEO
Sold after exercise
8,419
$16.23
$136.62K
James G McArthur
6 Jun 2023
President and CEO
Sold after exercise
18,150
$16.18
$293.66K
James G McArthur
5 Jun 2023
President and CEO
Sold after exercise
500
$16.06
$8.03K
James G McArthur
2 Jun 2023
President and CEO
Sold after exercise
1,800
$16.04
$28.86K
Jaya Goyal
24 Mar 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
392
$20.00
$7.84K
Jaya Goyal
8 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
644
$17.00
$10.95K
Jaya Goyal
7 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
3,679
$17.18
$63.21K
Jaya Goyal
6 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
1,677
$17.04
$28.57K
Niels Svenstrup
19 Dec 2022
SVP, Chem. Mfg & Controls
Exercised, kept
10,000
$2.71
$27.10K
James E Flynn
10 May 2022
10% owner
Buy indirect
208,333
$12.00
$2.50M
James E Flynn
10 May 2022
10% owner
Buy indirect
208,333
$12.00
$2.50M
Ra Capital Management, L.p.
10 May 2022
Director
Buy indirect
249,749
$12.00
$3.00M
Ra Capital Management, L.p.
10 May 2022
Director
Buy indirect
2,979,451
$12.00
$35.75M
Laurie Keating
6 May 2022
Director
Buy
4,166
$12.00
$49.99K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 9,848,749
History held since 10 May 2022